WS
AGN

Wedbush Securities’s Allergan plc AGN Stock Holding History

Wedbush Securities’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,232
Closed -$572K – 1031
2020
Q1 		$572K Sell
3,232
-111
-3% -$20.9K 0.07% 316
2019
Q4 		$639K Sell
3,343
-409
-11% -$73.8K 0.06% 376
2019
Q3 		$631K Sell
3,752
-1,082
-22% -$176K 0.06% 359
2019
Q2 		$809K Sell
4,834
-3,255
-40% -$451K 0.08% 279
2019
Q1 		$1.18M Buy
8,089
+1,284
+19% +$186K 0.13% 187
2018
Q4 		$910K Buy
6,805
+351
+5% +$57.5K 0.12% 216
2018
Q3 		$1.23M Buy
6,454
+27
+0.4% +$4.96K 0.14% 166
2018
Q2 		$1.07M Sell
6,427
-929
-13% -$149K 0.13% 177
2018
Q1 		$1.24M Buy
7,356
+4,491
+157% +$753K 0.16% 145
2017
Q4 		$469K Sell
2,865
-4,461
-61% -$801K 0.06% 404
2017
Q3 		$1.5M Buy
7,326
+1,650
+29% +$384K 0.2% 105
2017
Q2 		$1.38M Sell
5,676
-119
-2% -$28K 0.18% 124
2017
Q1 		$1.39M Buy
5,795
+2,976
+106% +$693K 0.19% 113
2016
Q4 		$592K Buy
2,819
+694
+33% +$144K 0.09% 289
2016
Q3 		$489K Buy
2,125
+665
+46% +$163K 0.07% 329
2016
Q2 		$337K Buy
1,460
+148
+11% +$34.1K 0.06% 410
2016
Q1 		$352K Buy
1,312
+366
+39% +$105K 0.06% 365
2015
Q4 		$296K Sell
946
-1,386
-59% -$413K 0.05% 409
2015
Q3 		$634K Sell
2,332
-399
-15% -$123K 0.13% 182
2015
Q2 		$829K Buy
2,731
+435
+19% +$130K 0.15% 159
2015
Q1 		$683K Buy
2,296
+44
+2% +$12.5K 0.12% 199
2014
Q4 		$580K Buy
2,252
+7
+0.3% +$1.75K 0.09% 230
2014
Q3 		$542K Buy
2,245
+318
+17% +$71.2K 0.08% 246
2014
Q2 		$430K Buy
+1,927
New +$399K 0.07% 291

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Wedbush Securities's AGN Position: Q2 2020 in Review

Wedbush Securities sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,232 shares — an estimated $572K sold.

Wedbush Securities first reported a position in AGN in Q2 2014 and held it in 24 quarters. The position peaked at $1.5M in Q3 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Wedbush Securities reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Wedbush Securities sold 3,232 Allergan plc shares in Q2 2020, an estimated $572K.
  • Wedbush Securities first reported a position in Allergan plc in Q2 2014 and held it in 24 quarters.
  • Wedbush Securities's Allergan plc position peaked at $1.5M in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Wedbush Securities's 13F filing for Q2 2020, filed 16 Jul 2020.